SEVERAL IMPORTANT clinical laboratory associations are concerned that the lab test price reporting under the Patient Access to Medicare Act of 2014 will have a negative effect on diagnostic innovation and on Medicare beneficiaries’ access to lab testing services. The American Clinical Laboratory Association wants to ensure that the new Medicare Part B clinical laboratory […]
To access this post, you must purchase The Dark Report.